Yugabyte Joins the Microsoft Intelligent Data Platform Partner Ecosystem
Simple, Automated Connectivity of YugabyteDB with Microsoft Azure Synapse Analytics Eliminates Silos Between Transactional Data…
News
Wolters Kluwer Tax + Accounting CEO Karen Abramson Wins Globee® in 15th Annual Women World Awards®
Abramson recognized for leading Wolters Kluwer Tax and Accounting tech transformation; expanding product portfolio into…
Eideticom awarded two new computational storage patents
SAN FRANCISCO–(BUSINESS WIRE)–Eideticom, the leader in NVMe® Computational Storage, today announced it has been recently…
Bobcat Company Celebrates Completion of Manufacturing Facility Expansion in Statesville, N.C.
$70 million investment makes Statesville the company’s largest manufacturing facility in North America and will…
NuStar Energy L.P. to Announce Third Quarter 2022 Earnings Results on November 3, 2022
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that it will host a conference…
Talkdesk Announces 2022 CX Innovator Award Winners
Highlighting companies that have championed and reshaped their customer experience using Talkdesk technology SAN FRANCISCO–(BUSINESS…
Dedrone Launches Low Collateral Counter-Drone Jammer for Urban Environments
New solution joins Dedrone’s successful DroneDefender Jammer, which has sold over 700 precision jammers for…
William Blair Continues Investment Banking Growth in Europe with New Tech Managing Director
CHICAGO & LONDON–(BUSINESS WIRE)–William Blair, the premier global boutique with expertise in investment banking, investment…
Freelance Payroll Solution Solar Staff Launches in the USA
The company provides U.S. businesses with an opportunity to pay freelancers from emerging markets like…
Axiom Exhibiting at Outsourcing in Clinical Trials New England 2022
TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
Loos, France, Isovital Headquarter, Oct 12th 2022 – Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW SHAREHOLDER
Loos, France, Isovital Headquarter, Oct 12th 2022 – Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW…
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
Novel name reflects expansion of capabilities and solutions SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE)…
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
TEL AVIV, Israel, Oct. 12, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC), a specialty…
AIM ImmunoTech Announces FDA Clearance of IND Application to Evaluate Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions
Company expects to commence patient enrollment and dosing in Q1 2023 OCALA, Fla, Oct. 12,…
Junshi Biosciences and Coherus Announce Publication of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, in the Journal of Clinical Oncology
Toripalimab in combination with chemotherapy was associated with significant improvements in PFS and OS compared…
T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
LEXINGTON, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader…
Albireo to Participate in H.C. Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference
BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease…
T2 Biosystems Announces Reverse Stock Split Effective Today
TTOO common stock expected to begin trading on a split-adjusted basis on October 13, 2022…
Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022
Six abstracts selected for presentation, including three oral presentations WALTHAM, Mass., Oct. 12, 2022 (GLOBE…
Viridian Therapeutics Announces Presentations at the American Thyroid Association 91st Annual Meeting
– Three late-breaking presentations to feature emerging evidence of VRDN-001 efficacy and differentiation – –…